Real world data: Trastuzumab w/o concurrent endocrine therapy in luminal HER2-positive metastatic breast cancer resulted in decreased overall survival

Autor:	J. Citic, Ana Cvetanovic, Z. Murtezani, I. Kezic, S. Susnjar, G. Matovina-Brko, A. Stojanovic, Siniša Radulović, Dusica Gavrilovic, N. Milosavljevic, N. Nedovic, I. Kolarov-Bjelobrk, Lazar Popovic, M. Popovic, N. Stanic, K. Serovic
Rok vydání:	2018
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Endocrine therapy medicine.disease Metastatic breast cancer Trastuzumab Internal medicine Overall survival Medicine business Real world data medicine.drug
Zdroj:	European Journal of Cancer. 92:S112
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(18)30561-6
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b720e850477ac2b878de964ba7f408e5 https://doi.org/10.1016/s0959-8049(18)30561-6 Zobrazit plný text záznamu Full Text from ScienceDirect